SEC Form D · Amendment · filed July 19, 2019
Finch Therapeutics Group, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (22)
Carter G. Mcnabb · Louisville, CODirectorMichael Galgon · Seattle, WADirectorGabriel Haddad Silva · Grand Cayman, Cayman IslandsDirectorLair G. Kennedy · Louisville, COExecBracken T. Darrell · Boston, MAExec · DirectorAllison Harr · Seattle, WADirectorKerry Song · San Clemente, CAExecAlexander T. Edwards · Boston, MAExecBryan Y. Colwell · New York, NYDirectorDavid T. Sinclair · Boston, MAExecJackie N. Charlesworth · Hong Kong, Hong KongDirectorMatthew N. Whitehead · Hong Kong, Hong KongExec · DirectorMilton Berlinski · New York, NYDirectorPeter Aberg · New York, NYDirectorTodd Haskins · New York, NYExecMarc N. Puglia · PROVIDENCE, RIExecPatrick Dunn · PROVIDENCE, RIExecHarry W. Lengsfield · NEW YORK, NYExecReiji Morooka · Tokyo, M0DirectorRuoyu Wang · San Francisco, CADirectorGreg A. Perry · Somerville, MAExecUlrich A. Thienel · Somerville, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗